YND1 interacts with CDC55 and is a novel mediator of E4orf4-induced toxicity

Tsofnat Maoz1, Roni Koren, Inbal Ben-Ari

  • 1The Gonda Center of Molecular Microbiology and The Rappaport Family Institute for Research in the Medical Sciences, Faculty of Medicine, Technion-Israel Institute of Technology, Bat Galim, Haifa, 31096, Israel.

Insights

Adenovirus E4orf4 protein triggers cell death via a network involving yeast apyrase Ynd1p and protein phosphatase 2A. This interaction, crucial for cell viability, is disrupted by E4orf4, leading to toxicity.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Virology

Background:

  • Adenovirus E4orf4 protein induces apoptosis and growth arrest.
  • Oncogenic transformation increases cell sensitivity to E4orf4.
  • Understanding the E4orf4 network is key to its unique cell death induction.

Purpose of the Study:

  • Identify components of the E4orf4 network.
  • Investigate E4orf4's role in apoptosis and growth arrest.
  • Explore interactions between E4orf4, Ynd1p, and Cdc55p.

Main Methods:

  • Yeast genetics for gene deletion screening.
  • Assessing E4orf4-induced toxicity and growth arrest.
  • Co-immunoprecipitation to study protein interactions.

Main Results:

  • YND1 deletion conferred partial resistance to E4orf4.
  • Ynd1p and Cdc55p (PP2A-B subunit) additively contributed to E4orf4 toxicity.
  • E4orf4 disrupted the physical interaction between Ynd1p and Cdc55p.
  • Mammalian homologue of Ynd1p (NTPDase-4) also interacted with E4orf4.

Conclusions:

  • Ynd1p and Cdc55p share a common target, crucial for cell viability.
  • E4orf4 disrupts this balance, leading to cell death.
  • Yeast findings are relevant to mammalian systems.

Related Concept Videos

DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Eukaryotic Transcription Inhibitors01:52

Eukaryotic Transcription Inhibitors

Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...